Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04593147 · ClinicalTrials.gov registry record · NA
Phase II Growth and Safety Study of an Infant Formula for Healthy Term Infants
A NA study, sponsored by Building Block Nutritionals.
- Completed
- Registry status
- NA
- Development phase
- 131
- Enrollment target
NCT04593147: Completed NA study, sponsored by Building Block Nutritionals.
NCT04593147 is a NA study that has completed, run by Building Block Nutritionals. The registered enrollment target is 131 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04593147, a NA study, has completed, sponsored by Building Block Nutritionals.
- COMPLETED
- Registry status
- NA
- Development phase
- 131 participants
- Enrollment target
Study Summary
A goal of infant formula development is to mimic human milk (HM) both in nutrient composition as well as physiologic outcomes. investigators have developed an infant formula for term infants that more closely resembles the composition of human milk. The purpose of this study is to demonstrate that this formulation meets nutritional requirements and supports age appropriate growth of healthy term infants.
Primary Outcome
Change grams per day
Interventions
- OTHER BBN
- OTHER Brand
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2020-10-14 |
| Est. Completion | 2021-11-09 |
| Phase | NA |
What the finished NCT04593147 record still lists
NCT04593147 is an interventional study that assigns participants to a tested intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which BBN is the first listed.
NCT04593147 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04593147 about?
NCT04593147 is a clinical study titled "Phase II Growth and Safety Study of an Infant Formula for Healthy Term Infants". A goal of infant formula development is to mimic human milk (HM) both in nutrient composition as well as physiologic outcomes. investigators have developed an infant formula for term infants that more closely resembles the composition of human milk. The purpose of this study is to demonstrate that t...
What is the current status of trial NCT04593147?
This trial is currently completed. It is a NA study. The enrollment target is 131 participants. The study started on 2020-10-14. Estimated completion is 2021-11-09.
What interventions are being tested in trial NCT04593147?
The interventions under investigation include: BBN (OTHER), Brand (OTHER).
Who is sponsoring clinical trial NCT04593147?
This trial is sponsored by Building Block Nutritionals, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04593147's enrollment target sits among peer trials
131 732nd of 2000 higher than 1,268 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI